It carries concentrated growth factors that support faster, more visible healing and better serum absorption right where the skin needs it
In March 2025, Roche entered into an outstanding licensing agreement and collaboration with Zealand Pharma for co-commercializing and co-developing petrelintide as a standalone therapy and a fixed-dose combination with Roches lead incretin asset CT-388
Orthopedics: Keeping Your Bones and Joints Healthy By Bob Berendsen February 5, 2025 Orthopedics is a medical specialty focused on the diagnosis, treatment, and prevention of conditions affecting the bones, joints, muscles, ligaments, and tendons
Users report improvements in low libido and sexual dysfunction, resulting in improved sexual wellness and overall sexual satisfaction
Through acylation technology, researchers engineered cagrilintide to persist in the body for an entire week